Replies to post #16309 on Synaptogenix Inc (SNPX)

[rayovacAAA]

IF ACCURATE, WHY HAS BRYOSTATIN NOT BEEN GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR AD BY THE FDA???????????????????

Laurie, we know that somewhere between 70 and 90% of non namenda patients who have MMSE scores >10 have improved test scores on bryostatin on multiple test and compassionate use patients.